Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Strander

Showing results (41-50 of 114) with videos related to

Pageof 12
Sort By:
Clinical and Experimental Immunology|February 1, 1970
Interferon response of lymphocytes in disorders with decreased resistance to infectionsH Strander, K Cantell, J Leisti, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Treatment of advanced condylomata acuminata with semi-purified and purified human leukocyte interferonN Einhorn, P Ling, D Secher, et al.
American Journal of Clinical Oncology|February 1, 1985
Adjuvant chemotherapy of malignant melanoma. A pilot studyJ Hansson, U Ringborg, B Lagerlöf, et al.
Acta Medica Scandinavica|January 1, 1979
Effect of prolonged in vivo administration of leukocyte interferon on the mitogen responsiveness of human lymphocytesS Einhorn, H Blomgren, K Cantell, et al.
Journal of Clinical & Laboratory Immunology|May 1, 1987
The capacity of blood lymphoid cells to produce alpha- and gamma-interferon is decreased during alpha-interferon therapyS Einhorn, P Ling, N Einhorn, et al.
Acta Oncologica (Stockholm, Sweden)|October 16, 1999
Effects of a nursing intervention on subjective distress, side effects and quality of life of breast cancer patients receiving curative radiation therapy--a randomized studyY Wengström, C Häggmark, H Strander, et al.
International Journal of Cancer|October 15, 1980
Virus infections and recurrence of osteosarcoma in patients receiving human leukocyte interferonS Ingimarsson, G Carlström, K Cantell, et al.
American Journal of Clinical Oncology|June 1, 1990
Dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A phase I-II trialU Ringborg, U Jungnelius, J Hansson, et al.
Clinical and Experimental Immunology|February 1, 1983
In vitro and in vivo effects of interferon on the response of human lymphocytes to mitogensS Einhorn, H Blomgren, N Einhorn, et al.
Anticancer Research|July 25, 1998
Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcomaC Linder, S Linder, E Munck-Wikland, et al.
Pageof 12

Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Clinical and Experimental Immunology|February 1, 1970
Interferon response of lymphocytes in disorders with decreased resistance to infectionsH Strander, K Cantell, J Leisti, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Treatment of advanced condylomata acuminata with semi-purified and purified human leukocyte interferonN Einhorn, P Ling, D Secher, et al.
American Journal of Clinical Oncology|February 1, 1985
Adjuvant chemotherapy of malignant melanoma. A pilot studyJ Hansson, U Ringborg, B Lagerlöf, et al.
Acta Medica Scandinavica|January 1, 1979
Effect of prolonged in vivo administration of leukocyte interferon on the mitogen responsiveness of human lymphocytesS Einhorn, H Blomgren, K Cantell, et al.
Journal of Clinical & Laboratory Immunology|May 1, 1987
The capacity of blood lymphoid cells to produce alpha- and gamma-interferon is decreased during alpha-interferon therapyS Einhorn, P Ling, N Einhorn, et al.
Acta Oncologica (Stockholm, Sweden)|October 16, 1999
Effects of a nursing intervention on subjective distress, side effects and quality of life of breast cancer patients receiving curative radiation therapy--a randomized studyY Wengström, C Häggmark, H Strander, et al.
International Journal of Cancer|October 15, 1980
Virus infections and recurrence of osteosarcoma in patients receiving human leukocyte interferonS Ingimarsson, G Carlström, K Cantell, et al.
American Journal of Clinical Oncology|June 1, 1990
Dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A phase I-II trialU Ringborg, U Jungnelius, J Hansson, et al.
Clinical and Experimental Immunology|February 1, 1983
In vitro and in vivo effects of interferon on the response of human lymphocytes to mitogensS Einhorn, H Blomgren, N Einhorn, et al.
Anticancer Research|July 25, 1998
Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcomaC Linder, S Linder, E Munck-Wikland, et al.
Pageof 12